Search
for
Sort by
Research 301–330 of 1000+
- Evaluation of serum 25-hydroxy vitamin D levels in alopecia areata of scalp: a cross sectional observational study
- Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience
- Using qualitative methods to establish the clinically meaningful threshold for treatment success in alopecia areata
- European expert consensus statement on the systemic treatment of alopecia areata
- Progressive alopecia areata during TNF-α inhibition with intralesional corticosteroid failure and subsequent improvement following JAK1 inhibition
- Effectiveness and safety of Baricitinib in alopecia areata: a prospective cohort study
- Ritlecitinib in Alopecia Areata: A 24‐Week Real‐World Experience Contrasting JAK Inhibitor‐Naïve and JAK Inhibitor‐Experienced Patients
- COMPARATIVE EVALUATION OF EFFICACY AND SAFETY OF TOPICAL METHOTREXATE WITH TRETINOIN VERSUS BETAMETHASONE WITH TRETINOIN IN PATIENTS OF ALOPECIA AREATA: A PROSPECTIVE RANDOMIZED DOUBLE-BLIND STUDY
- Real‐life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24‐week Italian study
- Efficacy of Oral Apremilast in The Treatment of Alopecia Areata, at The Tertiary Care Hospital, Karachi
- When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials
- Efficacy of mesalazine in children with moderate to severe alopecia areata: case series of 18 patients
- Treatment of alopecia areata in pre‐adolescent children with oral tofacitinib: A retrospective study
- Safety and efficacy of microneedling with autologous platelet-rich plasma in chronic and stable alopecia areata
- Trichoscopy as an evaluation method for alopecia areata treatment: A comparative study
- Efficacy and Safety of Topical Corticosteroid Treatment under Occlusion for Severe Alopecia Areata in Children. A single-center retrospective analysis
- Endocrinology and auxology of sibships with non-classical congenital adrenal hyperplasia.
- Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism
- STRIAA (Severity TRichoscopy Index Alopecia Areata): Validation of a Novel Trichoscopic Tool for Evaluation of Alopecia Areata
- Hearing impairment in patients with alopecia areata
- Hair regeneration after epidermal peeling
- Wiederbehaarung bei einem Patienten mit Alopecia universalis und Psoriasis vulgaris unter Deucravacitinib‐Therapie
- Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?
- Update on pulse corticosteroid therapy for the management of alopecia areata
- Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata
- Does zinc have a role in alopecia areata? A clinic-biochemical study
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Expert consensus on systemic treatment activation and grading evaluation for alopecia areata
- Race and Ethnicity Sub-Groups of Alopecia Areata Patients have Differing Clinical Characteristics: TARGET-DERM AA